These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9207003)

  • 1. An interleukin 5 mutant distinguishes between two functional responses in human eosinophils.
    McKinnon M; Page K; Uings IJ; Banks M; Fattah D; Proudfoot AE; Graber P; Arod C; Fish R; Wells TN; Solari R
    J Exp Med; 1997 Jul; 186(1):121-9. PubMed ID: 9207003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of IL-5-mediated signal transduction, eosinophil survival, and inflammatory mediator release by a soluble human IL-5 receptor.
    Monahan J; Siegel N; Keith R; Caparon M; Christine L; Compton R; Cusik S; Hirsch J; Huynh M; Devine C; Polazzi J; Rangwala S; Tsai B; Portanova J
    J Immunol; 1997 Oct; 159(8):4024-34. PubMed ID: 9378992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of interleukin-5 in immune regulation and inflammation].
    Takatsu K
    Nihon Rinsho; 2004 Oct; 62(10):1941-51. PubMed ID: 15500144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligation of the beta2 integrin triggers activation and degranulation of human eosinophils.
    Kato M; Abraham RT; Okada S; Kita H
    Am J Respir Cell Mol Biol; 1998 May; 18(5):675-86. PubMed ID: 9569238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of the interleukin-5 receptor antagonist peptide, AF18748.
    Rosas M; Uings IJ; van Aalst C; Lammers JW; Koenderman L; Coffer PJ
    Cytokine; 2004 Jun; 26(6):247-54. PubMed ID: 15183842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophil development and bone marrow and tissue eosinophils in atopic asthma.
    Robinson DS; North J; Zeibecoglou K; Ying S; Meng Q; Rankin S; Hamid Q; Tavernier J; Kay AB
    Int Arch Allergy Immunol; 1999; 118(2-4):98-100. PubMed ID: 10224350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-5 and its receptor: which role do they play in the immune response?
    Koike M; Takatsu K
    Int Arch Allergy Immunol; 1994 May; 104(1):1-9. PubMed ID: 7950399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-5- and eosinophil-mediated inflammation: from discovery to therapy.
    Kouro T; Takatsu K
    Int Immunol; 2009 Dec; 21(12):1303-9. PubMed ID: 19819937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5.
    Yamaguchi T; Kimura H; Kurabayashi M; Kozawa K; Kato M
    Immunol Lett; 2008 Jun; 118(1):88-95. PubMed ID: 18440651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of IL-5 signal transduction.
    Adachi T; Alam R
    Am J Physiol; 1998 Sep; 275(3):C623-33. PubMed ID: 9730944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergic diseases: From bench to clinic - Contribution of the discovery of interleukin-5.
    Yanagibashi T; Satoh M; Nagai Y; Koike M; Takatsu K
    Cytokine; 2017 Oct; 98():59-70. PubMed ID: 28863833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner.
    Walsh GM; Hartnell A; Wardlaw AJ; Kurihara K; Sanderson CJ; Kay AB
    Immunology; 1990 Oct; 71(2):258-65. PubMed ID: 2228026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 5 in the link between the innate and acquired immune response.
    Takatsu K; Kouro T; Nagai Y
    Adv Immunol; 2009; 101():191-236. PubMed ID: 19231596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-33 requires CMRF35-like molecule-1 expression for induction of myeloid cell activation.
    Shik D; Moshkovits I; Karo-Atar D; Reichman H; Munitz A
    Allergy; 2014 Jun; 69(6):719-29. PubMed ID: 24735452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine-induced protein tyrosine phosphorylation is essential for cytokine priming of human eosinophils.
    van der Bruggen T; Kanters D; Tool AT; Raaijmakers JA; Lammers JW; Verhoeven AJ; Koenderman L
    J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):103-9. PubMed ID: 9449508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Src homology 2 protein tyrosine phosphatase (SHPTP2)/Src homology 2 phosphatase 2 (SHP2) tyrosine phosphatase is a positive regulator of the interleukin 5 receptor signal transduction pathways leading to the prolongation of eosinophil survival.
    Pazdrak K; Adachi T; Alam R
    J Exp Med; 1997 Aug; 186(4):561-8. PubMed ID: 9254654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice.
    Rothenberg ME; Ownbey R; Mehlhop PD; Loiselle PM; van de Rijn M; Bonventre JV; Oettgen HC; Leder P; Luster AD
    Mol Med; 1996 May; 2(3):334-48. PubMed ID: 8784786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-3 Maintains Activation of the p90S6K/RPS6 Pathway and Increases Translation in Human Eosinophils.
    Esnault S; Kelly EA; Shen ZJ; Johansson MW; Malter JS; Jarjour NN
    J Immunol; 2015 Sep; 195(6):2529-39. PubMed ID: 26276876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of interleukin 5 receptors on eosinophilic sublines from human promyelocytic leukemia (HL-60) cells.
    Plaetinck G; Van der Heyden J; Tavernier J; Faché I; Tuypens T; Fischkoff S; Fiers W; Devos R
    J Exp Med; 1990 Sep; 172(3):683-91. PubMed ID: 2388031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced eosinophil luminol-dependent chemiluminescence and complement receptor expression by platelet-activating factor and interleukin-5.
    Tsai JJ; Yu LN; Wang SR
    Asian Pac J Allergy Immunol; 1993 Jun; 11(1):5-11. PubMed ID: 8216559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.